CD40 anticorps (C-Term)

N° du produit ABIN7295186

L’anticorps anti-CD40 Polyclonal Lapin est utilisé pour la détection de CD40 dans des échantillons de Humain, Souris, Chien et Porc. Il a été validé pour WB, IHC et IF.

Aperçu rapide pour CD40 anticorps (C-Term) (ABIN7295186)

Antigène: CD40

Reactivité: Humain, Souris, Chien, Porc

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CD40 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)

Détail du produit anti-CD40 anticorps

Épitope: C-Term

Fonction: Rabbit polyclonal antibody to CD40

Specificité: Recognizes endogenous levels of CD40 protein.

Attributs du produit: Rabbit polyclonal antibody to CD40

Purification: The antibody was purified by immunogen affinity chromatography.

Immunogène: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human CD40. The exact sequence is proprietary.

Information d'application

Indications d'application: WB (1/500 - 1/1000), IH (1/100 - 1/200), IF/IC (1/100 - 1/500)

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.

Date de péremption: 12 months

Détails sur CD40

Antigène: CD40

Autre désignation: CD40

Sujet: TNFRSF5, Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, Bp50, CD40L receptor, CDw40, CD40

ID gène: 958, 21939

UniProt: P25942

Pathways: Signalisation NF-kappaB, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints